The Insulin Management Advisor from Crossings Healthcare Solutions is available to help physicians manage complex inpatient hyperglycemic states effectively in a critical care setting. By leveraging the Cerner MPage platform, Crossings Healthcare was able to design a tool with embedded decision support that can improve patient outcomes and reduce variance across your organization.

Four advisors were created for Insulin Management:

  • Diabetic Ketoacidosis
  • Hyperglycemic Hyperosmolar state
  • Post Cardiac Surgery Insulin Advisor
  • Critical Care Insulin Advisor

2015 Inaugural Cerner Intelligence Connect Competition Winner: Enhancing Inpatient Insulin Management

Crossings Healthcare Solutions was honored with the inaugural Intelligence Connect award at the 2015 Cerner Health Conference for the success of Crossings’ creation of their Insulin Advisors. Marreddy Yeruva, MD, Assistant Chief Medical Information Officer at UHS of Delaware, Inc. along with Chuck Moore, Senior Nursing Informaticist received the award. The Cerner engineering vice presidents were impressed with the Advisors level of intelligence, innovation and value.

Diabetic Ketoacidosis Advisor

Innovative tool with inbuilt decision support, based on American Diabetic Association guidelines, that provides comprehensive evidence-based treatment recommendations to clinicians. These include intravenous fluid management, acidosis and anion gap correction, glucose correction, electrolytes replacement and effective subcutaneous insulin transition once anion gap has been corrected.

  • Based on ADA guidelines.

Diabetic Ketoacidosis Insulin Advisor Gallery

See an example of the Insulin Advisor

Hyperglycemic Hyperosmolar State Advisor

Innovative tool with inbuilt decision support, based on American Diabetic Association guidelines, that provides comprehensive evidence-based treatment recommendations to clinicians. These include intravenous fluid management, osmolality and anion gap correction, glucose correction, electrolytes replacement and effective subcutaneous insulin transition once serum osmolality and anion gap has been corrected.

  • Based on ADA guidelines.

Hyperosmolar Hyperglycemia State Insulin Infusion Protocol Advisor

See an example of the Insulin Advisor

Post Cardiac Surgery Insulin Advisor

Innovative tool with inbuilt decision support, customized from clinical content from Portland Diabetes project, that provides comprehensive evidence-based intravenous and subcutaneous insulin treatment recommendations to clinicians. This tool effectively achieves glycemic control during cardiac surgery perioperative period.

  • Evidence-based protocol
  • Target Glucose Range 110 to 150 mg/ dL

Critical Care Insulin Advisor

Innovative tool with inbuilt decision support, customized from  clinical content from Portland Diabetes project, that provides comprehensive evidence based intravenous and subcutaneous insulin treatment recommendations to clinicians. This tool effectively achieves glycemic control during ICU stay.

  • Evidence-based protocol
  • Target Glucose Range 140 to 180 mg/ dL

Critical Care Insulin Advisor Gallery

See examples of the Insulin Advisor